Cargando…
Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study
INTRODUCTION: Immunotherapy is a well-established treatment option in patients with metastatic melanoma. However, biomarkers that can be used to predict a response in these patients have not yet been found, putting patients at risk of severe side effects. METHODS: In this retrospective analysis, we...
Autores principales: | Richtig, Georg, Hoeller, Christoph, Wolf, Martin, Wolf, Ingrid, Rainer, Barbara M., Schulter, Günter, Richtig, Markus, Grübler, Martin R., Gappmayer, Anna, Haidn, Thomas, Kofler, Julian, Huegel, Rainer, Lange-Asschenfeldt, Bernhard, Pichler, Martin, Pilz, Stefan, Heinemann, Akos, Richtig, Erika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166940/ https://www.ncbi.nlm.nih.gov/pubmed/30273398 http://dx.doi.org/10.1371/journal.pone.0204729 |
Ejemplares similares
-
Problems and challenges of predatory journals
por: Richtig, G., et al.
Publicado: (2018) -
Function and Clinical Implications of Long Non-Coding RNAs in Melanoma
por: Richtig, Georg, et al.
Publicado: (2017) -
Prediction of Response in Melanoma Therapy by Systemic Inflammatory Response – One Size Fits Not All
por: Richtig, Georg, et al.
Publicado: (2017) -
ASCO Congress 2018: melanoma treatment
por: Richtig, Erika
Publicado: (2018) -
Predatory journals: Perception, impact and use of Beall’s list by the scientific community–A bibliometric big data study
por: Richtig, Georg, et al.
Publicado: (2023)